QT Imaging (NASDAQ:QTI) & Nexeon Medsystems (OTCMKTS:NXNN) Head to Head Analysis

Nexeon Medsystems (OTCMKTS:NXNN) and QT Imaging (NASDAQ:QTI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Insider & Institutional Ownership

24.2% of QT Imaging shares are held by institutional investors. 61.2% of Nexeon Medsystems shares are held by company insiders. Comparatively, 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Nexeon Medsystems and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexeon Medsystems	N/A	N/A	N/A
QT Imaging	-111.40%	N/A	-144.16%

Earnings and Valuation

This table compares Nexeon Medsystems and QT Imaging”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A
QT Imaging	$18.92 million	3.47	-$8.98 million	($2.54)	-2.17

Nexeon Medsystems has higher earnings, but lower revenue than QT Imaging.

Volatility & Risk

Nexeon Medsystems has a beta of 6.98, indicating that its share price is 598% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Nexeon Medsystems and QT Imaging, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexeon Medsystems	0	0	0	0	0.00
QT Imaging	1	0	1	0	2.00

Given Nexeon Medsystems’ higher probable upside, equities analysts plainly believe Nexeon Medsystems is more favorable than QT Imaging.

Summary

Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.

About Nexeon Medsystems

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.